Allen Kerry, Damery Sarah L, Sein Kim, Johnson David W, Davies Simon J, Lambie Mark, Holvoet Els, Combes Gill M
Health Services Management Centre, University of Birmingham, Edgbaston, UK.
Institute for Applied Health Research, University of Birmingham, Edgbaston, UK.
Perit Dial Int. 2022 May;42(3):297-304. doi: 10.1177/0896860820975596. Epub 2020 Dec 17.
While numerous studies have explored the patient experience of dialysis or other end-stage kidney disease (ESKD) treatments, few have explored the process of transitioning between dialysis modalities. This study aimed to develop an in-depth understanding of patient and caregiver perceptions and experiences of the transition from peritoneal to haemodialysis (HD) and to identify ways in which transitions can be optimised.
Fifty-four in-depth, semi-structured interviews were undertaken at six study sites across the West Midlands, UK ( = 23), and Queensland, Australia ( = 31). Thirty-nine participants were patients with ESKD; the remainder were family members. An inductive analytical approach was employed, with findings synthesised across sites to identify themes that transcended country differences.
Of the 39 patient transitions, only 4 patients reported a wholly negative transition experience. Three cross-cutting themes identified common transition experiences and areas perceived to make a difference to the treatment transition: resistance to change and fear of HD; transition experience shared with family; and bodily adjustment and sense of self.
Although each transition is unique to the individual and their circumstances, kidney care services could optimise the process by recognising these patient-led themes and developing strategies that engage with them. Kidney care services should consider ways to keep patients aware of potential future treatment options and present them objectively. There is potential value in integrating expert support before and during treatment transitions to identify and address patient and family concerns.
尽管众多研究探讨了透析或其他终末期肾病(ESKD)治疗的患者体验,但很少有研究探讨透析方式之间的转换过程。本研究旨在深入了解患者及照料者对从腹膜透析过渡到血液透析(HD)的认知和体验,并确定优化转换过程的方法。
在英国西米德兰兹郡(n = 23)和澳大利亚昆士兰州(n = 31)的六个研究地点进行了54次深入的半结构化访谈。39名参与者为ESKD患者,其余为家庭成员。采用归纳分析方法,综合各地点的研究结果以确定超越国家差异的主题。
在39例患者的转换中,只有4例患者报告了完全负面的转换体验。确定了三个贯穿各方面的主题,这些主题体现了常见的转换体验以及被认为对治疗转换有影响的方面:对改变的抵触和对HD的恐惧;与家人共同的转换体验;以及身体调整和自我认知。
尽管每次转换对个体及其情况而言都是独特的,但肾脏护理服务可以通过认识到这些以患者为主导的主题并制定与之相关的策略来优化转换过程。肾脏护理服务应考虑采取措施,让患者了解潜在的未来治疗选择并客观地向他们介绍这些选择。在治疗转换之前和期间整合专家支持以识别并解决患者和家庭的担忧具有潜在价值。